Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Abuse Deterrent Pharmaceuticals (AD Pharma) is a specialty pharmaceutical company dedicated to the development of advanced drug formulations that discourage the misuse and abuse of controlled substances. The company's core focus lies in applying proprietary technology to create physical and chemical barriers in medications such as opioids and stimulants, making them difficult to crush, dissolve, or inject. By enhancing the safety profile of these essential treatments, AD Pharma addresses a critical need in the public health landscape regarding the opioid crisis and prescription stimulant abuse. Headquartered in Louisville, Kentucky, the company works closely with strategic partners to bring these abuse-deterrent options to the clinical and commercial markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Abuse Deterrent Pharmaceuticals.